Find your next paid study

Devalingam MahalingamNCT07042919

~$10 – $7,500

Phase 1

A Feasibility Study of Integrated Delivery of Hypofractionated Pelvic IMRT With Carboplatin and Paclitaxel in Stage III Copy-Number Low and Copy-Number High Subtypes of Endometrial Cancer

The purpose of this study is to find out whether short-course radiation therapy (1 week instead of the usual 5 weeks) with chemotherapy (carboplatin and paclit…

Endometrial CancerStage III Endometrial CancerStage III Endometrial Carcinoma+2 more

Memorial Sloan Kettering Cancer CenterNCT05691010

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

This study evaluates the time spent on obtaining insurance approval and drugs, means of insurance coverage, out-of-pocket costs for patients, and the surgical …

Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more

Ohio State University Comprehensive Cancer CenterNCT07215988

~$10 – $750

Anterior Cruciate Ligament InjuriesPost-traumatic OsteoarthritisKnee Osteoarthritis+4 more

Gait Rehabilitation to Treat FastOA

The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-wee…

University of North Carolina, Chapel HillNCT05848622

Phase 2

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneration

A Phase 2, Randomized, Placebo-controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL-3007…

Geographic Atrophy Secondary to Age-related Macular Degeneration

Apellis Pharmaceuticals, Inc.NCT07215390

~$10 – $8,750

Barrett EsophagusEsophageal Adenocarcinoma

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma- R01 Aim 1a Renewal (SOS5C Trial)

This clinical trial studies how well minimally invasive approaches (an artificial intelligence \[AI\] powered risk tool, nurse navigation, and a sponge on a st…

Mayo ClinicNCT07206589

Randomized Controlled Clinical Trial To Assess The Safety And Effectiveness Of A Periodontal Hydrogel Wound Dressing (Emanate Perio PODS) On Wound Healing Post-Scaling And Root Planing

The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel d…

Periodontitis (Stage 3)

McGuire InstituteNCT06914596

~$10 – $7,500

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

This study evaluates how useful and acceptable the components of the "Couples Coping Together Against Cancer", referred to as "The Program", are to the partici…

Anatomic Stage IV Breast Cancer AJCC v8GlioblastomaLung Carcinoma+2 more

City of Hope Medical CenterNCT07664579

~$10 – $750

Phase 2

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

To determine the effect of low dose azacitidine therapy on tumor infiltrating lymphocytes (TILs) in primary tumors from patients with high-risk early stage bre…

Breast Cancer InvasiveEarly-stage Breast CancerHigh Risk Breast Carcinoma

University of Illinois at ChicagoNCT04891068

Phase 1

A Global First-in-Human Study in NSCLC, HNSCC, and Solid Tumors With Azirkitug as a Single Agent and in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease …

Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more

A Randomized, Multicenter, Open-Label, Phase 2 Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

This study will assess the efficacy, safety, optimal dose and ADA and NAbs development of TRK-950 at two separate dose levels in combination with ramucirumab a…

Gastric AdenocarcinomaGastric CancerGastroesophageal Junction Adenocarcinoma

Toray Industries, IncNCT06038578

~$10 – $8,750

End Stage Kidney Disease (ESRD)

A Pivotal Study to Evaluate the Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and Arteriovenous Fistula Maturation

The AMPLIFI-1 Study is a prospective, multicenter pivotal clinical trial designed to evaluate the safety and effectiveness of the Amplifi™ Vein Dilation System…